Abstract
Hepatocellular carcinoma is among the most common solid tumors, ranking behind only lung and gastric for cancer-related deaths worldwide. Despite improved surveillance programs in many countries, most patients present with advanced-stage cancer and chronic hepatic dysfunction limiting the available treatment options. This article reviews the most pertinent randomized controlled trials with respect to surgical and adjuvant interventions that shape the current treatment algorithm for hepatocellular carcinoma.
Original language | English (US) |
---|---|
Pages (from-to) | 151-162 |
Number of pages | 12 |
Journal | Surgical Oncology Clinics of North America |
Volume | 19 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2010 |
Keywords
- Evidence-based medicine
- Hepatocellular carcinoma
- Management
- Randomized controlled trials
ASJC Scopus subject areas
- Surgery
- Oncology